Synopsis
Synopsis
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Amethocaine
2. Ametop
3. Dicaine
4. Hydrochloride, Tetrracaine
5. Pantocaine
6. Pontocaine
7. Tetracaine
8. Tetracaine Monohydrochloride
9. Tetrakain
10. Tetrracaine Hydrochloride
1. 136-47-0
2. Tetracaine Hcl
3. Butethanol
4. Amethocaine Hydrochloride
5. Pantocaine
6. Curtacain
7. Menonasal
8. Anethaine
9. Dicainum
10. Tetracaine, Hcl
11. Tetracaine (hydrochloride)
12. Butylocaine
13. 2-(dimethylamino)ethyl 4-(butylamino)benzoate Hydrochloride
14. Tetocaine
15. Tetraca
16. Tetracainehydrochloride
17. 5nf5d4opci
18. 2-(dimethylamino)ethyl P-(butylamino)benzoate Monohydrochloride
19. Nsc-757337
20. 4-(butylamino)benzoic Acid 2-(dimethylamino)ethyl Ester Hydrochloride
21. Benzoic Acid, 4-(butylamino)-, 2-(dimethylamino)ethyl Ester, Monohydrochloride
22. Mls000069780
23. Tetracaine Hydrochloride (pontocaine)
24. Anethain
25. Decicain
26. Decicaine
27. Dessicain
28. Intercaine
29. Leocaine
30. Pantocain
31. Smr000058522
32. Tonexol
33. Anacel
34. Gingicain M
35. Dsstox_cid_22448
36. Dsstox_rid_80027
37. Dsstox_gsid_42448
38. Tetracainium Chloridum
39. Tetracaine Chlorhydrate
40. 2-(dimethylamino)ethyl 4-(butylamino)benzoate;hydrochloride
41. Viractin
42. Tetracaine Monohydrochloride
43. Amethocaine Monohydrochloride
44. Sr-01000075240
45. Ncgc00016049-02
46. Cas-136-47-0
47. Einecs 205-248-5
48. Unii-5nf5d4opci
49. Exactacain
50. Amethocalne Hcl
51. Tetracaine Hydrochloride [usp:jan]
52. Mfcd00038912
53. P-butylaminobenzoyl-2-dimethylaminoethanol Hydrochloride
54. 2-dimethylaminoethanol 4-n-butylaminobenzoate Hydrochloride
55. Pontocaine Hydrochloride
56. 2-(dimethylamino)ethyl P-(butylamino)benzoate Hydrochloride
57. Tetracaini Hydrochloridum
58. Opera_id_1220
59. P-(butylamino)benzoic Acid, 2-(dimethylamino)ethyl Ester, Hydrochloride
60. Dicainum [who-ip]
61. Schembl24370
62. Mls002222164
63. Protocaine Hydrochloride (tn)
64. Spectrum1500564
65. 4-butylaminobenzoic Acid Dimethylaminoethyl Ester Hcl
66. Chebi:9469
67. Chembl1255654
68. Dtxsid6042448
69. Tetracaine For System Suitability
70. Tetracaine Hydrochloride, >=99%
71. Hms1569d04
72. Hms1921c17
73. Pharmakon1600-01500564
74. Act04762
75. Bcp26339
76. Hy-b0473
77. Tox21_110290
78. Tox21_501211
79. Ac-774
80. Ccg-39266
81. Nsc757337
82. S2573
83. Tetracaine Hydrochloride [mi]
84. Tetracaine Hydrochloride (jp17/usp)
85. Tetracaine Hydrochloride [jan]
86. Akos015888160
87. Tox21_110290_1
88. Ks-5059
89. Lp01211
90. Nsc 757337
91. Benzoic Acid, P-(butylamino)-, 2-(dimethylamino)ethyl Ester, Monohydrochloride
92. Tetracaine Hydrochloride [mart.]
93. Tetracaine Hydrochloride [vandf]
94. Ncgc00016049-07
95. Ncgc00094458-01
96. Ncgc00094458-02
97. Ncgc00094458-03
98. Ncgc00094458-04
99. Ncgc00094458-05
100. Ncgc00261896-01
101. Tetracaine Hydrochloride [usp-rs]
102. Tetracaine Hydrochloride [who-dd]
103. Tetracaine Hydrochloride [who-ip]
104. 53762-93-9
105. Amethocaine Hydrochloride [who-ip]
106. Db-042341
107. Eu-0101211
108. Ft-0603346
109. Ft-0674941
110. Sw196411-3
111. T1688
112. Tetracaine Hydrochloride [green Book]
113. Tetracaine Hydrochloride [orange Book]
114. D00741
115. T 7508
116. Tetracaine Hydrochloride [ep Monograph]
117. Tetracaine Hydrochloride [usp Monograph]
118. Tetracaini Hydrochloridum [who-ip Latin]
119. 136t470
120. A807078
121. Kovanaze Component Tetracaine Hydrochloride
122. Tetracaine Hydrochloride, Sigma Reference Standard
123. Q-201806
124. Sr-01000075240-1
125. Sr-01000075240-6
126. Q27262597
127. Tetracaine Hydrochloride Component Of Kovanaze
128. Tetracaine Hydrochloride, Meets Usp Testing Specifications
129. Tetracaine Hydrochloride 1.0 Mg/ml In Acetonitrile (as Free Base)
130. Tetracaine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
131. Benzoic Acid, 4-(butylamino)-, 2-(dimethylamino)ethyl Ester,monohydrochloride
132. Tetracaine For System Suitability, European Pharmacopoeia (ep) Reference Standard
133. Tetracaine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
134. Tetracaine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 300.82 g/mol |
---|---|
Molecular Formula | C15H25ClN2O2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 9 |
Exact Mass | 300.1604557 g/mol |
Monoisotopic Mass | 300.1604557 g/mol |
Topological Polar Surface Area | 41.6 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 249 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anesthetics, Local
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22609
Submission : 2009-03-12
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22487
Submission : 2008-12-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-03-26
Pay. Date : 2015-03-18
DMF Number : 8221
Submission : 1989-09-21
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-06-01
Pay. Date : 2018-04-16
DMF Number : 32062
Submission : 2017-10-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4065
Submission : 1981-02-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-11-09
Pay. Date : 2022-09-27
DMF Number : 34462
Submission : 2021-06-22
Status : Active
Type : II
Certificate Number : CEP 2017-205 - Rev 01
Status : Valid
Issue Date : 2024-01-29
Type : Chemical
Substance Number : 57
Certificate Number : R1-CEP 2010-256 - Rev 01
Status : Valid
Issue Date : 2018-09-11
Type : Chemical
Substance Number : 57
Registration Number : 220MF10198
Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland
Initial Date of Registration : 2008-09-09
Latest Date of Registration : 2024-06-27
China's leading API and intermediate manufacturer, offering CMO/CDMO services and exports to 70+ countries, enhancing global health.
Date of Issue : 2023-11-06
Valid Till : 2026-11-05
Written Confirmation Number : SD230069
Address of the Firm : Economic Development Zone, Pingyuan County, Dezhou City, Shandong, PR China
Date of Issue : 2021-03-12
Valid Till : 2024-01-24
Written Confirmation Number : WC-0291n
Address of the Firm : Survey No. 69, Chandrapadiya (V), Vinjamur Mandal, Nellore District-524228
Date of Issue : 2018-01-25
Valid Till : 2021-01-24
Written Confirmation Number : WC-0291
Address of the Firm : Survey No. 69, Chandrapadiya (V), Vinjamur Mandal, Nellore District-524228
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-108
Start Marketing Date : 2024-10-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66219-0002
Start Marketing Date : 2009-12-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0269
Start Marketing Date : 1998-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1mg/mg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 79572-034
Start Marketing Date : 2021-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 22568-1029
Start Marketing Date : 2021-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0566
Start Marketing Date : 2014-08-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-1241
Start Marketing Date : 2013-06-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0142
Start Marketing Date : 2021-06-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17381-100
Start Marketing Date : 2010-05-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-7680
Start Marketing Date : 1990-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
58
PharmaCompass offers a list of Tetracaine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tetracaine Hydrochloride manufacturer or Tetracaine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tetracaine Hydrochloride manufacturer or Tetracaine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Tetracaine Hydrochloride API Price utilized in the formulation of products. Tetracaine Hydrochloride API Price is not always fixed or binding as the Tetracaine Hydrochloride Price is obtained through a variety of data sources. The Tetracaine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A TETRACAINE HCL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TETRACAINE HCL, including repackagers and relabelers. The FDA regulates TETRACAINE HCL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TETRACAINE HCL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of TETRACAINE HCL manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A TETRACAINE HCL supplier is an individual or a company that provides TETRACAINE HCL active pharmaceutical ingredient (API) or TETRACAINE HCL finished formulations upon request. The TETRACAINE HCL suppliers may include TETRACAINE HCL API manufacturers, exporters, distributors and traders.
click here to find a list of TETRACAINE HCL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A TETRACAINE HCL DMF (Drug Master File) is a document detailing the whole manufacturing process of TETRACAINE HCL active pharmaceutical ingredient (API) in detail. Different forms of TETRACAINE HCL DMFs exist exist since differing nations have different regulations, such as TETRACAINE HCL USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A TETRACAINE HCL DMF submitted to regulatory agencies in the US is known as a USDMF. TETRACAINE HCL USDMF includes data on TETRACAINE HCL's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The TETRACAINE HCL USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of TETRACAINE HCL suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The TETRACAINE HCL Drug Master File in Japan (TETRACAINE HCL JDMF) empowers TETRACAINE HCL API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the TETRACAINE HCL JDMF during the approval evaluation for pharmaceutical products. At the time of TETRACAINE HCL JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of TETRACAINE HCL suppliers with JDMF on PharmaCompass.
A TETRACAINE HCL CEP of the European Pharmacopoeia monograph is often referred to as a TETRACAINE HCL Certificate of Suitability (COS). The purpose of a TETRACAINE HCL CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of TETRACAINE HCL EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of TETRACAINE HCL to their clients by showing that a TETRACAINE HCL CEP has been issued for it. The manufacturer submits a TETRACAINE HCL CEP (COS) as part of the market authorization procedure, and it takes on the role of a TETRACAINE HCL CEP holder for the record. Additionally, the data presented in the TETRACAINE HCL CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the TETRACAINE HCL DMF.
A TETRACAINE HCL CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. TETRACAINE HCL CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of TETRACAINE HCL suppliers with CEP (COS) on PharmaCompass.
A TETRACAINE HCL written confirmation (TETRACAINE HCL WC) is an official document issued by a regulatory agency to a TETRACAINE HCL manufacturer, verifying that the manufacturing facility of a TETRACAINE HCL active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting TETRACAINE HCL APIs or TETRACAINE HCL finished pharmaceutical products to another nation, regulatory agencies frequently require a TETRACAINE HCL WC (written confirmation) as part of the regulatory process.
click here to find a list of TETRACAINE HCL suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing TETRACAINE HCL as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for TETRACAINE HCL API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture TETRACAINE HCL as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain TETRACAINE HCL and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a TETRACAINE HCL NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of TETRACAINE HCL suppliers with NDC on PharmaCompass.
TETRACAINE HCL Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of TETRACAINE HCL GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right TETRACAINE HCL GMP manufacturer or TETRACAINE HCL GMP API supplier for your needs.
A TETRACAINE HCL CoA (Certificate of Analysis) is a formal document that attests to TETRACAINE HCL's compliance with TETRACAINE HCL specifications and serves as a tool for batch-level quality control.
TETRACAINE HCL CoA mostly includes findings from lab analyses of a specific batch. For each TETRACAINE HCL CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
TETRACAINE HCL may be tested according to a variety of international standards, such as European Pharmacopoeia (TETRACAINE HCL EP), TETRACAINE HCL JP (Japanese Pharmacopeia) and the US Pharmacopoeia (TETRACAINE HCL USP).